Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2026-04-23 @ 3:16 PM
Study NCT ID:
NCT01369433
Status:
TERMINATED
Last Update Posted:
2020-09-01
First Post:
2010-03-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
Sponsor:
AVEO Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AV-951-09-901
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None